(*19*)
WASHINGTON: US biotechnology agency Moderna on Monday stated lab research confirmed its Covid-19 vaccine would stay protecting against variants of the coronavirus first recognized within the United Kingdom and South Africa.
“The research confirmed no important influence” on the extent of neutralizing antibodies elicited against the UK variant, B.1.1.7.
A six-fold discount in antibody ranges was noticed with the B.1.351 variant first seen in South Africa, however the ranges are thought to stay above what’s required for cover against Covid-19.
“The research confirmed no important influence” on the extent of neutralizing antibodies elicited against the UK variant, B.1.1.7.
A six-fold discount in antibody ranges was noticed with the B.1.351 variant first seen in South Africa, however the ranges are thought to stay above what’s required for cover against Covid-19.
(*19*)
(*19*)Source link
